{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:36:43Z","timestamp":1792820203106,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate community pharmacy\u2013based interventions for primary and secondary skin cancer prevention among individuals accessing pharmacy services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidance and was registered in the International Prospective Register of Systematic Reviews (CRD420261300767). Searches were conducted in five electronic databases, with the final search completed on 21 March 2026, and were complemented by Google Scholar and reference list screening. Studies published in English or Spanish between 1 January 2006 and 31 December 2025 were eligible if they evaluated community pharmacist-led or community pharmacy\u2013based activities related to photoprotection, skin cancer prevention, early detection, referral, or implementation. Study selection, data extraction, and methodological appraisal were performed independently by two reviewers. Methodological quality was assessed using Joanna Briggs Institute critical appraisal tools. Findings were synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Eleven studies published between 2008 and 2025 were included. Interventions addressed sun-safety education, photoprotection counselling, sunscreen use, medication-related photosensitivity counselling, awareness of skin cancer warning signs, risk assessment, lesion assessment, mole scanning, teledermatology-supported evaluation, and referral pathways. Overall, studies suggested improvements in knowledge, awareness, preventive intentions, short-term photoprotective actions, feasibility, and acceptability. However, the evidence showed methodological limitations, including limited comparator use, reliance on self-reported outcomes, incomplete follow-up, and inconsistent diagnostic confirmation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Community pharmacy represents a promising setting for primary and secondary skin cancer prevention. However, current evidence remains heterogeneous and largely observational. More robust controlled and implementation studies are needed to evaluate sustained behaviour change, diagnostic accuracy, referral outcomes, cost-effectiveness, and long-term clinical impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riag148","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:05:58Z","timestamp":1792771558000},"source":"Crossref","is-referenced-by-count":0,"title":["Community pharmacy\u2013based interventions for primary and secondary skin cancer prevention among individuals accessing pharmacy services: a systematic review"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7478-4727","authenticated-orcid":false,"given":"Guillermo J","family":"Pozuelo-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Seville , 41012 Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-6195","authenticated-orcid":false,"given":"Magdalena","family":"de Troya-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Universitario Costa del Sol , 29603 Marbella (Malaga) ,","place":["Spain"]},{"name":"RICAPPS \u2013 Network for Research on Chronicity, Primary Care, and Health Promotion , 29603 Marbella (Malaga) ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-0501","authenticated-orcid":false,"given":"Francisco","family":"Rivas Ruiz","sequence":"additional","affiliation":[{"name":"RICAPPS \u2013 Network for Research on Chronicity, Primary Care, and Health Promotion , 29603 Marbella (Malaga) ,","place":["Spain"]},{"name":"Research and Innovation Unit, Hospital Universitario Costa del Sol , 29603 Marbella (Malaga) ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-1698","authenticated-orcid":false,"given":"Maria","family":"Alvarez de Sotomayor","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Seville , 41012 Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2026102400370364900_ref1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2026102400370364900_ref2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2021.04.029","article-title":"Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943\u20132036","volume":"152","author":"Garbe","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026102400370364900_ref3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaad.2021.12.066","article-title":"Skin cancer: primary, secondary, and tertiary prevention. Part I","volume":"87","author":"Perez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026102400370364900_ref4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13187-020-01781-7","article-title":"Quality of life during treatment for Cervicofacial non-melanoma skin cancer","volume":"37","author":"Garc\u00eda-Montero","year":"2022","journal-title":"J Cancer Educ"},{"key":"2026102400370364900_ref5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jaad.2022.01.053","article-title":"Skin cancer: primary, secondary, and tertiary prevention. Part II","volume":"87","author":"Rojas","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026102400370364900_ref6","doi-asserted-by":"publisher","DOI":"10.2174\/18743722-v17-e230109-2022-20","article-title":"Personalized medical Photoprotection: determining optimal measures for susceptible patient groups","volume":"17:e187437222212300","author":"Gonz\u00e1lez","year":"2023","journal-title":"Open Dermatol J"},{"key":"2026102400370364900_ref7","doi-asserted-by":"publisher","first-page":"e12967","DOI":"10.1111\/phpp.12967","article-title":"New trends on personalized sunscreens","volume":"40","author":"Gracia-Caza\u00f1a","year":"2024","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026102400370364900_ref8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40264-019-00806-5","article-title":"Drug-induced photosensitivity\u2014an update: culprit drugs, prevention and management","volume":"42","author":"Blakely","year":"2019","journal-title":"Drug Saf"},{"key":"2026102400370364900_ref9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ddg.14314","article-title":"Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences","volume":"19","author":"Hofmann","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026102400370364900_ref10","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1111\/phpp.70001","article-title":"Personalized Photoprotection: expert consensus and recommendations from a Delphi study among dermatologists","volume":"41","author":"Troya-Mart\u00edn","year":"2025","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026102400370364900_ref11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jama.2017.21630","article-title":"Behavioral counseling for skin cancer prevention: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henrikson","year":"2018","journal-title":"JAMA"},{"key":"2026102400370364900_ref12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ypmed.2019.04.003","article-title":"The effects of community pharmacy-delivered public health interventions on population health and health inequalities: a review of reviews","volume":"124","author":"Thomson","year":"2019","journal-title":"Prev Med (Baltim)"},{"key":"2026102400370364900_ref13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.sapharm.2022.10.007","article-title":"Community pharmacy and primary health care - types of integration and their applicability: a narrative review","volume":"19","author":"Urionag\u00fcena","year":"2023","journal-title":"Res Soc Adm Pharm"},{"key":"2026102400370364900_ref14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.canep.2015.07.011","article-title":"Promoting the early detection of cancer: a systematic review of community pharmacy-based education and screening interventions","volume":"39","author":"Lindsey","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"2026102400370364900_ref15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026102400370364900_ref16","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"2026102400370364900_ref17","first-page":"87","article-title":"Pharmaceutical care when using drugs that may produce photosensitive reaction","volume":"10","author":"Moret Tatay","year":"2008","journal-title":"Pharm Care Esp"},{"key":"2026102400370364900_ref18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.18549\/PharmPract.2019.3.1455","article-title":"Role of community pharmacists in skin cancer screening: a descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain","volume":"17","author":"Mir","year":"2019","journal-title":"Pharm Pract (Granada)"},{"key":"2026102400370364900_ref19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.japh.2020.09.012","article-title":"Direct-to-consumer, store-and-forward teledermatology with dermoscopy using the pharmacist as patient point-of-contact","volume":"61","author":"Mendon\u00e7a","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"2026102400370364900_ref20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.33620\/FC.2173-9218.(2025).05","article-title":"Role of community pharmacies in the secondary prevention of skin cancer","volume":"17","author":"Gonz\u00e1lez Borrego","year":"2025","journal-title":"Farm Comunitarios"},{"key":"2026102400370364900_ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmacy8040231","article-title":"Accessing mole-scanning through community pharmacy: a pilot Service in Collaboration with dermatology specialists","volume":"8","author":"Kirkdale","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"2026102400370364900_ref22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ijpp.12251","article-title":"The case for targeting community pharmacy-led health improvement: findings from a skin cancer campaign in Wales","volume":"24","author":"Pearce","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"2026102400370364900_ref23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.sapharm.2016.12.001","article-title":"Dermatological cancer screening: evaluation of a new community pharmacy service","volume":"13","author":"Kjome","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"2026102400370364900_ref24","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1186\/s12889-023-17429-2","article-title":"The role of community pharmacists in primary and secondary prevention of skin cancer: an evaluation of a Flemish skin cancer prevention campaign","volume":"23","author":"Proesmans","year":"2023","journal-title":"BMC Public Health"},{"key":"2026102400370364900_ref25","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/healthcare11131907","article-title":"Sun protection Counseling at the pharmacy: a German qualitative study on status quo, potential deficits, and sources of information","volume":"11","author":"Diehl","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2026102400370364900_ref26","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.japh.2020.10.004","article-title":"SCAN! A pharmacy-based, sun safety feasibility study","volume":"61","author":"Kelly","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"2026102400370364900_ref27","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.japh.2023.09.004","article-title":"Assessing the impact of the skin cancer awareness now (SCAN!) intervention several months following the intervention","volume":"63","author":"Dhumal","year":"2023","journal-title":"J Am Pharm Assoc"},{"key":"2026102400370364900_ref28","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/cancers13102344","article-title":"Photosensitizing medications and skin cancer: a comprehensive review","volume":"13","author":"George","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026102400370364900_ref29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clindermatol.2021.08.014","article-title":"Photosensitizing drug reactions","volume":"40","author":"Montgomery","year":"2022","journal-title":"Clin Dermatol"},{"key":"2026102400370364900_ref30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.19677","article-title":"Photoprotection: current developments and controversies","volume":"38","author":"Pellacani","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026102400370364900_ref31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmjopen-2022-068207","article-title":"Diagnostic reliability in teledermatology: a systematic review and a meta-analysis","volume":"13","author":"Bourkas","year":"2023","journal-title":"BMJ Open"},{"key":"2026102400370364900_ref32","doi-asserted-by":"publisher","first-page":"e0298713","DOI":"10.1371\/journal.pone.0298713","article-title":"Factors influencing the uptake of public health interventions delivery by community pharmacists: a systematic review of global evidence","volume":"19","author":"Mumbi","year":"2024","journal-title":"PLoS One"},{"key":"2026102400370364900_ref33","doi-asserted-by":"publisher","first-page":"e086285","DOI":"10.1136\/bmjopen-2024-086285","article-title":"Strategic interventions and a novel model for the integration of community pharmacy and primary care in Spain: qualitative insights","volume":"14","author":"Piquer-Martinez","year":"2024","journal-title":"BMJ Open"},{"key":"2026102400370364900_ref34","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s11096-023-01590-0","article-title":"Economic evaluation of pharmacy services: a systematic review of the literature (2016\u20132020)","volume":"45","author":"Phimarn","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"2026102400370364900_ref35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag148\/72443963\/riag148.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag148\/72443963\/riag148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag148\/72443963\/riag148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:37:22Z","timestamp":1792816642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article\/doi\/10.1093\/ijpp\/riag148\/8993986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riag148","relation":{},"ISSN":["2042-7174"],"issn-type":[{"value":"2042-7174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"article-number":"riag148"}}